Coates As
Impact in
- Cancer Research top 10%
- Breast Cancer Treatment Studies
- Oncology top 10%
- Cutaneous Melanoma Detection and Management
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
- Cancer Risks and Factors
Papers in
- Oncology 4
- Cutaneous Melanoma Detection and Management 3
- Lung Cancer Research Studies 1
-
- Melanoma and MAPK Pathways 2
- Co-authors
- Beat Thürlimann (2 shared papers)RD Gelber (2 shared papers)Stefan Aebi (2 shared papers)I. D. Werner (1 shared paper)Monica Castiglione‐Gertsch (1 shared paper)J. Collins (1 shared paper)Diana Crivellari (1 shared paper)Shari Gelber (1 shared paper)
- Journals
- Annals of Oncology (2 papers)The Lancet (1 paper)PubMed (5 papers)
- Partner nations
- AustraliaSwitzerlandUnited States
In The Last Decade
Coates As
8 papers receiving 421 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 185
- Oncology 229
- Genetics 93
- Immunology 49
- Pathology and Forensic Medicine 30
Countries citing papers authored by Coates As
This map shows the geographic impact of Coates As's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Coates As with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Coates As more than expected).
Fields of papers citing papers by Coates As
This network shows the impact of papers produced by Coates As. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Coates As. The network helps show where Coates As may publish in the future.
Co-authors
The 25 scholars most cited alongside Coates As, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 213 | |
| 2 | Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial. | 1993 | 87 |
| 3 | 2011 | 67 | |
| 4 | Elective lymph node dissection in patients with primary melanoma of the trunk and limbs treated at the Sydney Melanoma unit from 1960 to 1991. | 1995 | 48 |
| 5 | 2009 | 11 | |
| 6 | Phase II study of doxorubicin and mitomycin in non-small cell bronchogenic carcinoma. | 1982 | 3 |
| 7 | Randomized trial of combination chemotherapy in hormone-resistant metastatic prostate carcinoma. | 1985 | 3 |
| 8 | Mitolactol chemotherapy for malignant melanoma: a phase II study. | 1984 | 3 |
About Coates As
Coates As is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Computational Theory and Mathematics, having authored 8 papers that have together received 435 indexed citations. Recurring topics across this work include Cutaneous Melanoma Detection and Management (3 papers), Melanoma and MAPK Pathways (2 papers), Lung Cancer Research Studies (1 paper), Computational Drug Discovery Methods (1 paper), Breast Cancer Treatment Studies (1 paper), Lung Cancer Treatments and Mutations (1 paper), Prostate Cancer Treatment and Research (1 paper) and Prostate Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Cancer Research (185 citations), Oncology (229 citations), Genetics (93 citations), Immunology (49 citations) and Pathology and Forensic Medicine (30 citations). Coates As has collaborated with scholars based in Australia, Switzerland and United States. Frequent co-authors include Beat Thürlimann, RD Gelber, Stefan Aebi, I. D. Werner, Monica Castiglione‐Gertsch, J. Collins, Diana Crivellari, Shari Gelber, H. Cortés-Funes and C.-M. Rudenstam. Their work appears in journals such as Annals of Oncology, The Lancet and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.